top of page

Oska Pulse進駐港澳
邁向7週年

革新婦科疼痛治療

全球醫療界長期面臨女性特有疼痛病症缺乏對症療法的困境，Oska Wellness以跨國臨床實證突破此醫療缺口。
本團隊研發之非侵入性技術已於國際權威醫療機構驗證效能，三大婦科難症臨床突破，針對下列迫切需求領域提供創新治療方案：

 

  • 間質性膀胱炎：在德國著名的呂訥堡診所（Clinic of Lueneburg）對Oska Pulse進行臨床試驗中，在泌尿科權威專家Björn Kaftan博士的積極推薦下，即將成為德國官方推薦療法，為飽受此症困擾的女性提供急需的疼痛緩解。

​

  • 複雜性局部疼痛綜合症 (CRPS)：2023年10月，德國某大學附屬醫院將啟動雙盲研究。Oska Pulse已在美國幫助數百名女性有效控制這種疼痛，我們致力於為更多患者提供解決方案。

​

  • 子宮內膜異位症：全球知名大學附屬醫院將於10月在德國展開雙盲研究。雖然我們的設備並非根治方案，但已證實能顯著減輕炎症和緩解疼痛，助無數受此症影響的女性重拾正常的美好生活。

​​

此外，Oska Pulse已廣泛應用於緩解女性經期疼痛。

​​​​​​​​​

PEMF療法於子宮內膜異位症之臨床應用

探索PEMF療法在子宮內膜異位症治療潛力：最新臨床研究進展

子宮內膜異位症是一種全球性慢性疾病，影響數百萬女性健康。此病症以反覆發作的週期性及非週期性劇烈疼痛為主要特徵，嚴重損害患者生活品質。傳統治療模式如荷爾蒙療法與外科手術，雖能緩解部分症狀，卻普遍存在療效局限與副作用明顯等困境。值得期待的是，近年醫療科技突破為創新療法開闢了新方向，為患者帶來新的曙光。以脈衝電磁場（PEMF）療法為代表的非藥物介入模式，目前正由CVK腫瘤外科中心的婦科權威Prof. Dr. Sylvia Mechsner領銜臨床研究進行驗證。

 

什麼是PEMF療法？
脈衝電磁場（PEMF）療法透過低頻電磁場激活細胞修復，並調控促炎因子分泌以實現抗炎效應。該療法已涵蓋骨折修復延遲、退化性關節炎及慢性神經病理性疼痛等領域。此研究特別聚焦於傳統療法反應不佳或存在手術禁忌症患者群體，系統性評估PEMF作為二線治療方案的臨床價值。

 

臨床研究概覽
這項名為「脈衝電磁場（PEMF）刺激對子宮內膜異位症患者的臨床效果——隨機對照雙盲先導研究」的試驗，旨在驗證PEMF刺激是否能改善患者的症狀與生活品質。研究將採用醫療設備Oska Pulse，於患處或附近區域進行84天治療。受試者需每日使用設備至少兩次、每次三小時，亦可於日常活動中持續佩戴，將治療裝置佩戴於日常外着衣物內層。


研究意義與展望
PEMF療法若證實有效，將為子宮內膜異位症治療開闢無創、無藥物或手術的新途徑，顯著提升患者生活品質。現有治療方法的局限性令此研究的突破意義更加重大。研究採用嚴格的雙盲隨機對照設計，並透過精準篩選受試者群體，確保數據可靠性，推動PEMF療法在臨床的廣泛應用。

 

結語
現有案例表明，Oska Pulse能持續緩解子宮內膜異位症症狀。Mechsner教授團隊的研究標誌著無創治療領域的重大進展。隨著電磁技術的深入應用，我們正逐步開啟疼痛管理與生活品質提升的新紀元。

深入瞭解：子宮內膜異位症完整解析

image 1a.png

Unlocking Relief for Women

Women have been living with painful conditions that do not have safe or successful treatments. Oska Wellness is looking to change that situation for women.

Our innovative technology has shown exceptional promise in three key areas of women's health where safe and effective treatments are greatly needed.

 

  • Interstitial Cystitis: Currently, during a clinical trial at the prestigious Clinic of Lueneburg in Germany, Oska Pulse is being championed by Dr. Björn Kaftan, a renowned specialist in urology. The device is poised to become a recommended treatment in Germany, providing much-needed relief for women suffering from this condition.

​

  • CRPS (Chronic Regional Pain Syndrome): A double-blind study will commence in October 2023 in Germany at a University Clinic. Oska Pulse has already proven its efficacy, helping hundreds of women in the US manage this debilitating pain, and we aim to provide even more solutions.

​

  • Endometriosis: A double-blind study will commence in October in Germany at a world renowned University clinic. This condition affects countless women, and our device, while not a cure, has demonstrated its power in reducing inflammation and pain, allowing women to lead more normal lives.

​

The Oska Pulse is also used successfully for women who suffer menstrual pain each month.​​

​​​​​​​​​

PEMF Therapy for Endometriosis

Exploring the Promise of PEMF Therapy for Endometriosis: An Update on the Latest Clinical Study

Endometriosis is a debilitating condition affecting millions of women worldwide, characterized by severe cyclical and acyclic pain that significantly impacts quality of life. Traditional treatment options, including hormone therapy and surgical interventions, often provide limited relief and come with their own set of challenges. However, recent developments in medical technology have opened the door to innovative therapies that may offer new hope for endometriosis patients. One such promising approach is Pulsed Electromagnetic Field (PEMF) stimulation, currently being investigated in a groundbreaking clinical study led by Univ.-Prof. Dr. Sylvia Mechsner at the Clinic for Gynecology with Center for Oncological Surgery CVK.

 

What is PEMF Therapy?
Pulsed Electromagnetic Field (PEMF) therapy involves using low-frequency electromagnetic fields to stimulate cellular repair and reduce inflammation. The therapy has been widely used for various medical conditions, including bone healing, arthritis, and chronic pain. The current study aims to explore its effectiveness in alleviating endometriosis-related symptoms, offering a potential alternative for women who have not found relief through traditional treatments.

 

The Clinical Study: Overview and Purpose
Titled "Clinical effects of pulsed electromagnetic field (PEMF) stimulation in patients with endometriosis – a randomized controlled double-blind pilot study," this clinical trial seeks to examine whether PEMF stimulation can improve symptoms and overall quality of life for women suffering from endometriosis. The study will utilize the medical device Oska Pulse, which will be applied to or near the affected area for 84 days. Participants will use the device for at least two sessions of three hours each day, wearing it under their outer clothing if necessary.


Potential Impact and Importance

he potential benefits of PEMF therapy for endometriosis are manifold. If successful, this study could pave the way for a non-invasive, drug-free treatment option that provides significant symptom relief for women suffering from this chronic condition. Given the limitations of current treatments, the implications for improved patient outcomes and enhanced quality of life could be profound.

Moreover, the double-blind, randomised, controlled design of the study ensures rigorous scientific scrutiny, increasing the reliability of the results. By focusing on a diverse group of participants who meet strict inclusion criteria, the research team aims to gather robust data that could lead to wider acceptance and application of PEMF therapy in clinical settings.

​

Conclusion

As we have seen, Oska Pulse patients receive continued relief from the chronic symptoms of endometriosis. We are positive that PEMF therapy stands out as a promising treatment alternative. This ongoing study led by Univ.-Prof. Dr. Sylvia Mechsner represents a significant step forward in our quest to offer effective, noninvasive treatment options for women struggling with endometriosis. By harnessing the power of electromagnetic fields, we may soon unlock new possibilities for pain relief and improved quality of life.

Read our Endometriosis Guide

bottom of page